A-285222

N/A

Report date: 2024/12/02 11:06:02

Base Information

Drug NameA-285222
Drug Alias NameA-158406A-169726A-169898A-204144A-285354 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-2 inhibitorsInterleukin-4 inhibitorsInterleukin-5 inhibitors +[4] 
TargetsInterleukin-2Interleukin-4Interleukin-5 +[4] 
Therapy Area/IndicationsRejection of organ transplantationAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbott Laboratories
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAsthma

Other Information

ATC CodeN/A
Related LinksN/A